Healthcare & Life Sciences News and Articles

Google_site External News

HSA Alert: Three Weight Loss Products Sold Online Found to Contain Banned Substance Sibutramine; Two Consumers Experienced Adverse Effects - Health Sciences Authority

news.google.com · 12 Jan 2024

Google_site External News

Recall of BD ChloraPrep™ Clear – 1 mL Applicator - hsa.gov.sg

news.google.com · 08 Jan 2024

Google_site External News

Severe cutaneous adverse reaction reports with modafinil and armodafinil - hsa.gov.sg

news.google.com · 15 Dec 2023

Industry News External News

Singapore hospitals struggle to meet demand for radiographers, pharmacists amid shortage in healthcare workers - CNA

news.google.com · 20 Oct 2023

Google News – EMA (biotech/pharma) External News

Spanish drugmaker Serra Pamies suffers manufacturing clampdown by EMA - Fierce Pharma

news.google.com · 22 Aug 2023

Google News – EMA (biotech/pharma) External News

EMA backs SV95C as digital primary endpoint for DMD trials - pharmaphorum

news.google.com · 09 Aug 2023

Google News – EMA (biotech/pharma) External News

Mirati's flagship KRAS inhibitor Krazati gets rebuffed in Europe - Fierce Pharma

news.google.com · 21 Jul 2023

Google News – EMA (biotech/pharma) External News

Paper outlines EMA's early thoughts on AI - The Pharmaletter

news.google.com · 19 Jul 2023

Google News – EMA (biotech/pharma) External News

Moderna submits EMA filing for updated COVID-19 jab - The Pharmaletter

news.google.com · 03 Jul 2023

Google News – Cardiology External News

What will Lodoco cost? Looking ahead after FDA’s historic approval of colchicine for CVD - Cardiovascular Business

news.google.com · 27 Jun 2023

Google News – EMA (biotech/pharma) External News

Batch of EMA/CHMP recommendations from June 2023 meeting - The Pharmaletter

news.google.com · 23 Jun 2023

Google News – Cardiology External News

Colchicine's Rebirth as Cardiovascular Drug Approved by FDA - MedPage Today

news.google.com · 20 Jun 2023

Google News – Cardiology External News

Agepha Pharma gets ancient gout remedy colchicine across FDA finish line for heart disease - Fierce Pharma

news.google.com · 20 Jun 2023

Google News – EMA (biotech/pharma) External News

Amylyx warns EMA unlikely to approve ALS drug AMX0035 - The Pharmaletter

news.google.com · 31 May 2023

Google News – EMA (biotech/pharma) External News

Six novel meds recommended for approval by EMA/CHMP - The Pharmaletter

news.google.com · 28 Apr 2023

News & Articles

From Roster to Resilience: Building a Workforce Risk Register

The Protocol-to-Workflow Specialist: A Career Emerging in Clinical Research

Build the Bench: Internal Mobility for Healthcare’s Hard-to-Fill Work

The Access Architect: A New Clinical Research Workforce Priority

Jury should decide if university’s hiring process was tainted by diversity goals, court rules

Running costs of vaccine damage scheme more than double amount paid to victims

CMS expands TAVR Medicare coverage to asymptomatic patients

Stryker stock falls on slower peripheral vascular, hip sales

Veterans Affairs taps Amwell for telehealth revamp - Healthcare Dive

8 stories on the healthcare affordability crunch

For women in the workforce, can AI be the ‘great equalizer’?

What building fair hiring under real regulation taught us, and why the U.S. is next

Inside L’Oréal’s hiring strategy behind 2 million applications a year

Campaigners hold vigil as stroke unit closes

Epidural Kit Correction: Medical Action Industries Issues Correction for Epidural Kits Containing Spectra Medical Devices Lidocaine Ampules

UK needs new laws for AI in healthcare, says watchdog

Migraines and acne among five more conditions pharmacists can treat

Maternal Mental Health Policy

4 questions about the FDA’s approach to generative AI

Presidential dialogue on high-threat pathogens

HSA Alert: Three Weight Loss Products Sold Online Found to Contain Banned Substance Sibutramine; Two Consumers Experienced Adverse Effects - Health Sciences Authority

Recall of BD ChloraPrep™ Clear – 1 mL Applicator - hsa.gov.sg

Severe cutaneous adverse reaction reports with modafinil and armodafinil - hsa.gov.sg

Singapore hospitals struggle to meet demand for radiographers, pharmacists amid shortage in healthcare workers - CNA

Spanish drugmaker Serra Pamies suffers manufacturing clampdown by EMA - Fierce Pharma

EMA backs SV95C as digital primary endpoint for DMD trials - pharmaphorum

Mirati's flagship KRAS inhibitor Krazati gets rebuffed in Europe - Fierce Pharma

Paper outlines EMA's early thoughts on AI - The Pharmaletter

Moderna submits EMA filing for updated COVID-19 jab - The Pharmaletter

What will Lodoco cost? Looking ahead after FDA’s historic approval of colchicine for CVD - Cardiovascular Business

Batch of EMA/CHMP recommendations from June 2023 meeting - The Pharmaletter

Colchicine's Rebirth as Cardiovascular Drug Approved by FDA - MedPage Today

Agepha Pharma gets ancient gout remedy colchicine across FDA finish line for heart disease - Fierce Pharma

Amylyx warns EMA unlikely to approve ALS drug AMX0035 - The Pharmaletter

Six novel meds recommended for approval by EMA/CHMP - The Pharmaletter